- Country: Czech Republic
- Summary: Selektivni Immunosupressiva - Antithymocytarni Immunoglobulin V.
- CZT Ref No: 80450620
- Deadline: 18 Apr 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: Z2023-010628
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Selective immunosuppressants - Antithymocyte immunoglobulin V.
Description of the order: The subject of the public order is the supply of medicinal preparations containing the active substance immunoglobulin antithymocytarum cuniculum (ATC L04AA04) with a concentration of 20mg/1ml (2%) for the treatment of patients in approved indications according to SPC platneho on the date of submission of the offer.
Value without VAT: 32,310,000.00
Currency: CZK
Date of publication in VVZ: 17.03.2023 20526
Type: Supplies
Place of delivery: Hl. city of Prague - IKEM - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSelektivni Immunosupressiva - Antithymocytarni Immunoglobulin V. - Czech Tender
The INSTITUTE OF CLINICAL AND EXPERIMENTAL MEDICINE, a Government sector organization in Czech Republic, has announced a new tender for Selektivni Immunosupressiva - Antithymocytarni Immunoglobulin V.. This tender is published on CzechTenders under CZT Ref No: 80450620 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-04-18.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
